123 related articles for article (PubMed ID: 15897587)
21. Pharmacokinetics of coumarin and 7-hydroxycoumarin in the rhesus monkey after intravenous and peroral administration.
Ritschel WA; Denson DD; Grummich KW
Arzneimittelforschung; 1988 Nov; 38(11):1619-23. PubMed ID: 3214445
[TBL] [Abstract][Full Text] [Related]
22. Phase I evaluation of oral and intravenous vinorelbine in pediatric cancer patients: a report from the Children's Oncology Group.
Johansen M; Kuttesch J; Bleyer WA; Krailo M; Ames M; Madden T
Clin Cancer Res; 2006 Jan; 12(2):516-22. PubMed ID: 16428494
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the safety and pharmacokinetics of ST-246® after i.v. infusion or oral administration in mice, rabbits and monkeys.
Chen Y; Amantana A; Tyavanagimatt SR; Zima D; Yan XS; Kasi G; Weeks M; Stone MA; Weimers WC; Samuel P; Tan Y; Jones KF; Lee DR; Kickner SS; Saville BM; Lauzon M; McIntyre A; Honeychurch KM; Jordan R; Hruby DE; Leeds JM
PLoS One; 2011; 6(8):e23237. PubMed ID: 21858040
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of the antiviral agent beta-L-3'-fluoro-2',3'-didehydro-2',3'-dideoxycytidine in rhesus monkeys.
Asif G; Hurwitz SJ; Gumina G; Chu CK; McClure HM; Schinazi RF
Antimicrob Agents Chemother; 2005 Feb; 49(2):560-4. PubMed ID: 15673733
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of ofloxacin in broiler chicken.
Kalaiselvi L; Sriranjani D; Ramesh S; Sriram P; Mathuram LN
J Vet Pharmacol Ther; 2006 Jun; 29(3):185-9. PubMed ID: 16669862
[TBL] [Abstract][Full Text] [Related]
26. Preclinical pharmacology of the novel antitumor agent adaphostin, a tyrphostin analog that inhibits bcr/abl.
Li M; Wang H; Hill DL; Stinson S; Veley K; Grossi I; Peggins J; Covey JM; Zhang R
Cancer Chemother Pharmacol; 2006 May; 57(5):607-14. PubMed ID: 16331493
[TBL] [Abstract][Full Text] [Related]
27. Enhanced oral bioavailability of DDI after administration of 6-Cl-ddP, an adenosine deaminase-activated prodrug, to chronically catheterized rats.
Anderson BD; Morgan ME; Singhal D
Pharm Res; 1995 Aug; 12(8):1126-33. PubMed ID: 7494823
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of temozolomide in association with fotemustine in malignant melanoma and malignant glioma patients: comparison of oral, intravenous, and hepatic intra-arterial administration.
Marzolini C; Decosterd LA; Shen F; Gander M; Leyvraz S; Bauer J; Buclin T; Biollaz J; Lejeune F
Cancer Chemother Pharmacol; 1998; 42(6):433-40. PubMed ID: 9788568
[TBL] [Abstract][Full Text] [Related]
29. Effect of short-term drinking water exposure to dichloroacetate on its pharmacokinetics and oral bioavailability in human volunteers: a stable isotope study.
Schultz IR; Shangraw RE
Toxicol Sci; 2006 Jul; 92(1):42-50. PubMed ID: 16611621
[TBL] [Abstract][Full Text] [Related]
30. Disposition and pharmacokinetics of the antimigraine drug, rizatriptan, in humans.
Vyas KP; Halpin RA; Geer LA; Ellis JD; Liu L; Cheng H; Chavez-Eng C; Matuszewski BK; Varga SL; Guiblin AR; Rogers JD
Drug Metab Dispos; 2000 Jan; 28(1):89-95. PubMed ID: 10611145
[TBL] [Abstract][Full Text] [Related]
31. Prediction of human oral pharmacokinetics using nonclinical data: examples involving four proprietary compounds.
Fura A; Vyas V; Humphreys W; Chimalokonda A; Rodrigues D
Biopharm Drug Dispos; 2008 Nov; 29(8):455-68. PubMed ID: 18989850
[TBL] [Abstract][Full Text] [Related]
32. Bioavailability and mammary excretion of bisphenol a in Sprague-Dawley rats.
Yoo SD; Shin BS; Lee BM; Lee KC; Han SY; Kim HS; Kwack SJ; Park KL
J Toxicol Environ Health A; 2001 Nov; 64(5):417-26. PubMed ID: 11700006
[TBL] [Abstract][Full Text] [Related]
33. Comparative pharmacokinetics of single doses of doxylamine succinate following intranasal, oral and intravenous administration in rats.
Pelser A; Müller DG; du Plessis J; du Preez JL; Goosen C
Biopharm Drug Dispos; 2002 Sep; 23(6):239-44. PubMed ID: 12214324
[TBL] [Abstract][Full Text] [Related]
34. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
[TBL] [Abstract][Full Text] [Related]
35. High performance liquid chromatographic analysis and preclinical pharmacokinetics of the heteroarotinoid antitumor agent, SHetA2.
Zhang Y; Hua Y; Benbrook DM; Covey JM; Dai G; Liu Z; Chan KK
Cancer Chemother Pharmacol; 2006 Nov; 58(5):561-9. PubMed ID: 16534614
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of doxycycline after a single intravenous, oral or intramuscular dose in Muscovy ducks (Cairina moschata).
Yang F; Sun N; Zhao ZS; Wang GY; Wang MF
Br Poult Sci; 2015; 56(1):137-42. PubMed ID: 25411077
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of the citrus flavanone aglycones hesperetin and naringenin after single oral administration in human subjects.
Kanaze FI; Bounartzi MI; Georgarakis M; Niopas I
Eur J Clin Nutr; 2007 Apr; 61(4):472-7. PubMed ID: 17047689
[TBL] [Abstract][Full Text] [Related]
38. Dose-dependent pharmacokinetics of a new Na+/H+ exchanger inhibitor KR-33028 in rats.
Kim YH; Yoo SD; Kim YS; Lee KH; Lee HS
Biopharm Drug Dispos; 2007 Nov; 28(8):423-9. PubMed ID: 17828714
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of difloxacin in pigs and broilers following intravenous, intramuscular, and oral single-dose applications.
Ding HZ; Yang GX; Huang XH; Chen ZL; Zeng ZL
J Vet Pharmacol Ther; 2008 Jun; 31(3):200-4. PubMed ID: 18471140
[TBL] [Abstract][Full Text] [Related]
40. Disposition of the antipsychotic agent CI-1007 in rats, monkeys, dogs, and human cytochrome P450 2D6 extensive metabolizers. Species comparison and allometric scaling.
Feng MR; Loo J; Wright J
Drug Metab Dispos; 1998 Oct; 26(10):982-8. PubMed ID: 9763403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
